Brief: Xspray Pharma Reports On FDA Pre-Approval Inspection
27/06/2025 14:57
June 27 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST: FDA PRE-APPROVAL INSPECTION INSPECTION CONFIRMS PRODUCTION OF DASYNOC IS FULLY COMPLIANT WITH CURRENT GOOD MANUFACTURING PRACTICE STANDARDS Source text: ID:nMFN4z1JWV Further company coverage: XSPRAY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))